BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25024164)

  • 21. Novel therapeutic approaches in chondrosarcoma.
    Polychronidou G; Karavasilis V; Pollack SM; Huang PH; Lee A; Jones RL
    Future Oncol; 2017 Mar; 13(7):637-648. PubMed ID: 28133974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Clinicopathological Features With Outcome in Chondrosarcomas of the Head and Neck.
    Asioli S; Ruengwanichayakun P; Zoli M; Guaraldi F; Sollini G; Greco P; Facco C; Gibertoni D; Jiménez BV; Benini S; Turri-Zanoni M; Pasquini E; Mazzatenta D; Foschini MP; Righi A
    Otolaryngol Head Neck Surg; 2021 Apr; 164(4):807-814. PubMed ID: 32928034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant IDH is sufficient to initiate enchondromatosis in mice.
    Hirata M; Sasaki M; Cairns RA; Inoue S; Puviindran V; Li WY; Snow BE; Jones LD; Wei Q; Sato S; Tang YJ; Nadesan P; Rockel J; Whetstone H; Poon R; Weng A; Gross S; Straley K; Gliser C; Xu Y; Wunder J; Mak TW; Alman BA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2829-34. PubMed ID: 25730874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
    Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
    Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
    de Andrea CE; San-Julian M; Bovée JVMG
    Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes.
    Bovée JV; Sciot R; Dal Cin P; Debiec-Rychter M; van Zelderen-Bhola SL; Cornelisse CJ; Hogendoorn PC
    Diagn Mol Pathol; 2001 Dec; 10(4):228-35. PubMed ID: 11763313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysis.
    Zhang Y; Paz Mejia A; Temple HT; Trent J; Rosenberg AE
    Hum Pathol; 2014 Jul; 45(7):1541-5. PubMed ID: 24792622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glandular differentiation in dedifferentiated chondrosarcoma: molecular evidence of a rare phenomenon.
    Jour G; Liu Y; Ricciotti R; Pritchard C; Hoch BL
    Hum Pathol; 2015 Sep; 46(9):1398-404. PubMed ID: 26198745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enchondromatosis and Growth Plate Development.
    Zhang H; Alman BA
    Curr Osteoporos Rep; 2021 Feb; 19(1):40-49. PubMed ID: 33306166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
    Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of Bcl10 mutations in malignant cartilaginous tumors.
    Park YK; Park HR; Kim YW; Chi SG; Unni KK
    Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
    van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen.
    Kawashima A; Ueda Y; Tsuchiya H; Tomita K; Nagai Y; Nakanishi I
    J Cancer Res Clin Oncol; 1993; 120(1-2):35-40. PubMed ID: 8270606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth.
    Li L; Hu X; Eid JE; Rosenberg AE; Wilky BA; Ban Y; Sun X; Galoian K; DeSalvo J; Yue J; Chen XS; Blonska M; Trent JC
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study.
    Oshiro Y; Chaturvedi V; Hayden D; Nazeer T; Johnson M; Johnston DA; Ordóñez NG; Ayala AG; Czerniak B
    Cancer; 1998 Dec; 83(11):2324-34. PubMed ID: 9840532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.
    Boeuf S; Kunz P; Hennig T; Lehner B; Hogendoorn P; Bovée J; Richter W
    J Pathol; 2008 Oct; 216(2):158-66. PubMed ID: 18702172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synovial osteochondromatosis of the knee and synovial chondrosarcoma. Report of 2 cases].
    Benoit J; Arnaud E; Moulucou A; Hardy P; Got C; Judet O
    Rev Chir Orthop Reparatrice Appar Mot; 1990; 76(3):198-203. PubMed ID: 2146713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of sarcomas by mutant IDH2.
    Lu C; Venneti S; Akalin A; Fang F; Ward PS; Dematteo RG; Intlekofer AM; Chen C; Ye J; Hameed M; Nafa K; Agaram NP; Cross JR; Khanin R; Mason CE; Healey JH; Lowe SW; Schwartz GK; Melnick A; Thompson CB
    Genes Dev; 2013 Sep; 27(18):1986-98. PubMed ID: 24065766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
    Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
    Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.